EMA — authorised 9 June 2009
- Marketing authorisation holder: GENZYME EUROPE BV
- Status: approved
🇪🇺 Renvela in European Union
EMA authorised Renvela on 9 June 2009
Marketing authorisation
Renvela in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Renvela approved in European Union?
Yes. EMA authorised it on 9 June 2009.
Who is the marketing authorisation holder for Renvela in European Union?
GENZYME EUROPE BV holds the EU marketing authorisation.